The pharmacy operator more than doubled its stake in the primary care provider and now plans to accelerate a co-location rollout plan.
Author: Fernando Moncada Rivera
Fernando Moncada Rivera is a reporter at Global Corporate Venturing and also host of the Global Venturing Review podcast.
Expensify logs IPO filing
The Barracuda Networks-backed expense management software provider has filed to go public having disclosed less than $28m in funding.
Weights and Biases bags $135m
The Bloomberg Beta-backed machine learning technology provider’s valuation passed the $1bn mark in a series C round which lifted its overall funding to $200m.
Lark treats itself to $100m
The Omron-backed preventative healthcare provider will use the series D funding to bolster research and development and expand its customer base.
Nothing bumps series A to $65m
The consumer technology producer secured a further $50m from undisclosed investors to expand a GV-backed round.
Corporates travel to SpringHill
LeBron James’ sports media company was valued at $725m in a round of undisclosed size that included Nike, Epic Games and Fenway Sports Group.
At-Bay amplifies series D round to $205m
The cybersecurity insurance provider added $20m from Ion Crossover Partners for a round already backed by Microsoft and Munich Re, at a $1.35bn valuation.
Tala tells of $145m series E round
Upstart, PayPal and J Safra Group participated in a round in which the microfinance platform developer reached an $800m valuation.
Elliptic decrypts $60m series C round
SoftBank Vision Fund 2, Wells Fargo Strategic Capital and SBI Group were among the investors filling up the risk analysis software provider’s coffers in its latest round.
Dragoneer drags in $75m from corporates
Fubon Financial Holdings’ Fubon Life subsidiary and CTBC Financial Holdings’ Taiwan Life are both backing Dragoneer Opportunities Fund VI.
M2P Fintech hauls in $35m
DMI Group was among the investors in a series C round valuing the banking API developer at $355m post-money.
Trumid traps $208m in funding
Singapore Exchange reinvested in the bond trading platform developer at a $2.4bn valuation, in a round led by Point Break Capital Management.
Hibob hits $150m in series C round
The Sumitomo and Seek-backed employee management software provider hiked its total funding to $274m in a round valuing it at $1.65bn.
CinCor Pharma bags $143m
Eli Lilly participated in a series B round for the cardiorenal treatment specialist that will support clinical drug trials, boosting its overall funding to $193m.